keyword
acut
rhinosinus
chronic
rhinosinus
nasal
polyp
infect
inflamm
asthma
microbiom
rhinosinus
clinic
defin
presenc
nasal
drainag
anterior
posterior
nasal
congest
facial
painpressur
andor
reduc
sens
smell
acut
rhinosinus
nasal
symptom
last
less
week
inflamm
often
secondari
viral
bacteri
infect
chronic
rhinosinus
cr
nasal
symptom
persist
longer
week
inflamm
observ
secondari
impair
epitheli
barrier
dysregul
host
immun
respons
potenti
infect
colon
pathogen
cr
asthma
strong
clinic
associ
share
similar
pathophysiolog
mechan
support
unifi
airway
hypothesi
acut
rhinosinus
ar
defin
presenc
nasal
drainag
anterior
posterior
nasal
congest
facial
painpressur
andor
reduc
sens
smell
depend
guidelin
follow
ar
symptom
last
either
less
week
week
ar
clinic
diagnosi
object
confirm
sinu
comput
tomographi
ct
scan
nasal
endoscopi
gener
indic
patient
one
episod
ar
year
importantli
asymptomat
interven
period
acut
rhinosinus
extrem
common
studi
specifi
ar
found
diseas
preval
estim
popul
suffer
recurr
episod
estim
million
ambulatori
care
visit
primari
diagnosi
ar
furthermor
alon
acut
upper
respiratori
infect
presum
ar
one
top
lead
diagnos
outpati
offic
visit
unifi
airway
hypothesi
suggest
nose
lung
separ
organ
system
instead
part
continuum
inflamm
upper
respiratori
tract
affect
lower
respiratori
tract
vice
versa
viral
bacteri
respiratori
pathogen
long
known
induc
acut
inflamm
airway
implic
develop
chronic
diseas
rhinosinus
asthma
common
respiratori
diseas
link
togeth
clinic
well
pathophysiolog
basi
fig
review
associ
rhinosinus
asthma
explor
particular
emphasi
place
role
infect
inflamm
certain
individu
may
predispos
rhinosinus
due
allerg
rhiniti
allergi
smoke
histori
mechan
obstruct
sinu
ostium
howev
patient
upper
respiratori
tract
infect
often
respons
ar
classic
divid
main
subtyp
base
caus
durat
symptom
acut
viral
sinus
last
less
day
rapid
peak
declin
nasal
symptom
common
virus
isol
ar
rhinovirus
coronavirus
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
enteroviru
adenoviru
also
caus
acut
upper
respiratori
symptom
persist
greater
day
symptom
initi
improv
worsen
acut
bacteri
rhinosinus
abr
consid
patient
addit
symptom
like
observ
includ
persist
purul
nasal
drainag
sever
facial
pain
fever
dental
pain
abr
gener
develop
follow
acut
viral
rhinosinus
overal
common
occurr
develop
case
pathogen
associ
acut
bacteri
rhinosinus
includ
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
staphylococcu
aureu
streptococcu
pyogen
sinc
introduct
pneumococc
conjug
vaccin
pathogen
profil
ar
chang
declin
incid
pneumonia
increas
incid
h
influenza
pyogen
aureu
anaerob
fusobacterium
peptostreptococcu
bacteroid
spp
account
smaller
percentag
abr
case
infect
gramneg
bacteria
unusu
commun
set
presenc
enterobacteriacea
pseudomona
spp
suggest
chronic
underli
condit
dental
infect
migrat
sinus
well
known
acut
upper
respiratori
infect
capabl
exacerb
preexist
asthma
howev
one
episod
ar
gener
associ
higher
risk
develop
asthma
per
se
discuss
earlier
preced
chapter
specif
pathogen
associ
ar
also
associ
develop
asthma
exampl
rsv
infect
infanc
risk
factor
develop
allerg
asthma
adolesc
likewis
human
rhinoviru
infant
also
associ
higher
incid
asthma
adult
elucid
key
mechanist
link
specif
viral
bacteri
pathogen
develop
new
onset
asthma
critic
better
understand
link
upper
lower
respiratori
tract
also
identifi
potenti
modifi
factor
could
lead
diseas
prevent
contrast
ar
chronic
rhinosinus
cr
character
chronic
inflamm
sinonas
mucosa
diagnosi
cr
made
clinic
patient
exhibit
anterior
posterior
nasal
drainag
nasal
congest
facial
pain
pressur
andor
decreas
sens
smell
greater
week
among
patient
report
cr
symptom
object
evid
chronic
inflamm
confirm
either
direct
visual
nasal
endoscopi
sinu
ct
scan
small
subset
patient
cr
also
nasal
polyp
benign
inflammatori
outgrowth
sinonas
mucosa
patient
aptli
refer
sinu
infect
inflamm
asthma
cr
nasal
polyp
crswnp
leav
remain
major
patient
cr
cr
without
nasal
polyp
crssnp
use
symptombas
criteria
overal
preval
cr
within
primari
care
us
popul
similar
earlier
studi
europ
report
preval
cr
among
tertiari
care
popul
howev
preval
cr
estim
even
higher
given
possibl
referr
bia
longitudin
studi
adult
report
cr
symptom
us
gener
popul
lifetim
preval
cr
estim
annual
cumul
incid
almost
comparison
lifetim
preval
asthma
adult
accord
nation
health
interview
survey
annual
cost
diseas
estim
billion
cr
billion
asthma
taken
togeth
asthma
cr
preval
within
us
popul
place
larg
socioeconom
financi
burden
affect
patient
health
care
system
relationship
cr
asthma
remain
great
interest
clinic
well
pathophysiolog
perspect
although
everi
patient
cr
asthma
vice
versa
strong
independ
associ
condit
report
larg
european
studi
asthma
preval
patient
cr
without
odd
ratio
furthermor
patient
crswnp
like
asthma
crssnp
one
studi
report
asthma
mani
patient
crswnp
compar
crssnp
studi
franc
also
found
asthmat
abnorm
sinu
ct
scan
similarli
asthmat
patient
cr
like
nasal
polyp
nonasthmat
patient
cr
exactli
patient
develop
cr
asthma
remain
unclear
cr
primarili
diseas
adulthood
given
sinus
entir
form
late
adolesc
diseas
includ
cystic
fibrosi
first
consid
children
present
nasal
polyp
although
asthma
develop
either
childhood
later
life
cr
significantli
link
adultonset
asthma
particular
patient
cr
like
develop
nasal
polyp
adultonset
versu
childhoodonset
diseas
asthma
may
preced
diagnosi
crswnp
develop
follow
diagnosi
crssnp
howev
like
time
frame
cr
asthma
develop
variabl
depend
varieti
yet
identifi
factor
associ
cr
asthma
import
clinic
implic
among
patient
cr
tertiari
care
facil
asthma
significantli
wors
sinu
ct
nasal
endoscop
score
compar
patient
cr
without
asthma
furthermor
sever
asthma
greater
likelihood
sever
cr
unit
state
sever
asthma
research
program
identifi
distinct
clinic
phenotyp
sever
asthma
cluster
asthmat
sever
airflow
limit
baselin
group
highest
percentag
report
sinu
diseas
although
asthma
influenc
sinonas
diseas
sever
cr
also
associ
sever
asthma
patient
cr
asthma
lower
lung
function
percentag
predict
forc
expiratori
volum
first
second
expir
forc
vital
capac
qualiti
life
compar
patient
asthma
alon
furthermor
sever
cr
independ
risk
factor
frequent
asthma
exacerb
patient
sever
asthma
like
undergo
sinu
surgeri
nasal
polyp
compar
patient
mild
asthma
final
compar
patient
crswnp
alon
crswnp
asthma
significantli
like
enhanc
sinonas
diseas
sinu
ct
scan
undergo
sinu
surgeri
depend
chronic
oral
corticosteroid
manag
diseas
taken
togeth
studi
highlight
fact
cr
asthma
frequent
associ
togeth
clinic
set
presenc
one
significantli
enhanc
sever
remain
import
evalu
patient
cr
asthma
well
asthmat
patient
cr
optim
diseas
diagnosi
manag
better
understand
mechan
contribut
clinic
associ
observ
cr
asthma
nasal
pulmonari
tissu
would
ideal
isol
time
patient
compar
surprisingli
studi
exceedingli
rare
one
investig
strong
correl
inflammatori
profil
observ
nasal
polyp
bronchial
biopsi
larger
mechanist
studi
also
separ
advanc
knowledg
underli
cellular
molecular
process
contribut
either
asthma
cr
pathogenesi
although
exhaust
summari
find
beyond
scope
current
review
focu
place
highlight
key
featur
cr
especi
comparison
asthma
mention
previous
strongest
associ
asthma
cr
observ
among
patient
crswnp
surpris
similar
observ
asthmat
nasal
polyp
unit
state
europ
predominantli
character
type
inflamm
eosinophil
well
granul
protein
eg
eosinophil
cation
protein
eosinophil
peroxidas
elev
nasal
polyp
compar
healthi
control
sinonas
tissu
type
immun
cell
includ
mast
cell
basophil
group
innat
lymphoid
cell
also
increas
nasal
polyp
robust
type
inflammatori
respons
orchestr
part
elev
level
prosurviv
chemotact
mediat
interleukin
eotaxin
thymic
stromal
lymphopoietin
contrast
crswnp
crssnp
origin
character
type
inflamm
due
elev
level
interferon
gamma
ifng
detect
subtyp
howev
subsequ
studi
challeng
dichotomi
shown
differ
ifng
level
observ
cr
subtyp
recent
comprehens
analysi
evalu
express
sever
inflammatori
mediat
differ
sinonas
tissu
cr
suggest
crssnp
instead
heterogen
diseas
work
patient
crssnp
predomin
type
phenotyp
assess
ifng
gene
express
level
percentil
observ
healthi
control
furthermor
patient
crssnp
increas
gene
express
type
inflammatori
mediat
percentil
measur
control
clinic
relev
differ
endotyp
crssnp
gener
weaker
associ
asthma
compar
crswnp
unclear
remain
focu
ongo
investig
adapt
immun
respons
also
character
cr
b
cell
thought
play
import
role
cell
produc
type
inflammatori
cytokin
increas
nasal
polyp
addit
b
cell
plasma
cell
elev
nasal
polyp
compar
healthi
control
total
level
antibodi
includ
immunoglobulin
e
ige
igg
significantli
higher
nasal
sinu
infect
inflamm
asthma
polyp
compar
peripher
blood
match
patient
well
healthi
sinonas
tissu
function
local
antibodi
product
well
specif
antibodi
gener
still
larg
unknown
howev
igg
antibodi
selfreact
ige
antibodi
aureu
enterotoxin
well
bacteria
h
influenza
describ
besid
enhanc
immunolog
respons
cr
also
character
dysfunct
epitheli
barrier
tight
junction
host
defens
protein
mucociliari
clearanc
factor
found
impair
find
regard
similar
report
lower
respiratori
tract
asthma
weaken
epitheli
barrier
profound
consequ
upper
lower
respiratori
tract
constantli
expos
million
microb
daili
healthi
host
microb
routin
clear
without
incit
inflammatori
respons
cr
process
impair
remain
unknown
impair
epitheli
barrier
lead
increas
pathogen
recognit
host
exposur
pathogen
respiratori
tract
lead
epitheli
barrier
damag
either
way
endpoint
could
initi
potenti
robust
immunolog
respons
aureu
known
colon
nasal
mucosa
one
studi
microb
cr
one
hypothesi
suggest
bacteria
directli
involv
drive
cr
pathogenesi
damag
epitheli
barrier
activ
host
immun
respons
ex
vivo
studi
nasal
polyp
explant
infect
aureu
show
reduc
gene
express
level
variou
tight
junction
protein
compar
similarli
infect
healthi
nasal
mucosa
addit
separ
studi
aureu
report
bind
induc
type
cytokin
releas
cultur
epitheli
cell
turn
could
potenti
explain
colon
aureu
nasal
caviti
could
lead
develop
chronic
immunolog
respons
howev
address
studi
patient
colon
aureu
go
develop
cr
furthermor
patient
crswnp
presenc
aureu
associ
sever
sinu
inflamm
ct
scan
sinonas
symptom
suggest
pathogen
alon
fulli
respons
aspect
diseas
anoth
hypothesi
immun
respons
aureu
import
cr
pathogenesi
support
type
inflammatori
mediat
significantli
elev
nasal
polyp
patient
detect
level
specif
ige
antibodi
aureu
enterotoxin
sae
correl
found
marker
presenc
aureu
tissu
specif
antibodi
sae
induc
basophil
degranul
mast
cell
activ
provid
anoth
possibl
mechan
aureu
could
contribut
chronic
type
inflamm
howev
separ
studi
although
patient
crswnp
like
elev
serum
level
specif
ige
sae
compar
healthi
control
associ
antibodi
level
sinu
diseas
sever
assess
ct
scan
import
note
patient
cr
colon
aureu
one
studi
report
colon
rate
cr
versu
healthi
control
likewis
patient
colon
aureu
detect
specif
ige
sae
howev
colon
aureu
presenc
specif
ige
sae
significantli
higher
patient
crswnp
asthma
respect
metaanalysi
nasal
aureu
colon
modestli
associ
asthma
preval
gener
popul
adjust
studi
bia
among
subset
patient
cr
howev
patient
detect
specif
ige
sae
like
sever
asthma
well
reduc
lung
function
increas
airway
revers
bronchodil
taken
togeth
specif
ige
sae
andor
aureu
may
import
cr
pathogenesi
relat
comorbid
asthma
select
group
patient
exact
mechan
associ
still
unclear
addit
aureu
bacteria
includ
coagulaseneg
staphylococci
h
influenza
pneumonia
moraxella
catarrhali
corynebacterium
spp
propionibacterium
acn
detect
sinonas
sampl
patient
cr
either
nasal
cultur
measur
bacteriaspecif
ribosom
dna
total
bacteri
count
correl
sinu
diseas
sever
compar
healthi
control
one
studi
found
patient
cr
significantli
lower
actinobacteria
level
lower
corynebacterium
spp
well
reduc
rel
abund
genu
peptoniphilu
differ
also
report
nasal
microbiom
patient
cr
without
asthma
one
studi
asthma
increas
abund
phylum
proteobacteria
catarrhali
staphylococcu
xylosu
decreas
abund
genu
corynebacterium
geobact
anodireducenssulfurreducen
pelomona
puraqua
separ
studi
cr
case
signific
differ
divers
bacteri
speci
note
patient
cr
without
asthma
although
rel
abund
streptococcu
spp
significantli
higher
patient
cr
asthma
compar
without
furthermor
asthmat
patient
cr
emerg
room
er
visit
asthma
significantli
higher
rel
abund
proteobacteria
phylum
like
due
increas
burkholderia
spp
patient
visit
er
symptom
find
interest
given
streptococcu
link
asthma
develop
children
burkholderia
associ
decreas
lung
function
patient
cystic
fibrosi
howev
bacteria
specif
involv
cr
pathogenesi
known
compar
frequenc
abund
divers
bacteria
patient
cr
observ
healthi
control
ideal
goal
would
identifi
particular
bacteria
could
protect
predispos
toward
develop
diseas
unfortun
studi
date
descript
without
causal
shown
addit
signific
variat
studi
differ
patient
demograph
within
sinonas
caviti
sampl
collect
data
gener
method
data
analyz
date
one
particular
pathogen
implic
cr
overal
increas
abund
decreas
divers
microbiom
observ
thu
like
differ
microbiom
import
cr
pathogenesi
link
cr
asthma
howev
studi
need
investig
key
factor
could
strong
import
relationship
upper
lower
respiratori
tract
wherebi
inflamm
one
environ
influenc
acut
rhinosinus
exposur
viral
bacteri
pathogen
primari
driver
acut
inflamm
nose
lead
exacerb
asthma
contrast
remain
unclear
precis
role
infect
colon
airway
play
sinu
infect
inflamm
asthma
develop
cr
factor
includ
presenc
impair
epitheli
barrier
dysregul
immun
respons
promot
chronic
inflamm
observ
cr
clinic
cr
strongli
associ
asthma
diseas
share
similar
underli
inflammatori
process
conclus
signific
advanc
made
identifi
sinu
infect
inflamm
import
asthma
pathogenesi
addit
work
need
defin
specif
mechan
respons
connect
nose
lung
